2m 2m 2m 2m 2m 2m 2m
NEUROONE MD TCH (NMTC)
NASDAQ
$3.34-$0.006 (-0.18%)
Price as of Jun 23, 2026 4:21 PM EDT- $28.3MMarket Cap
- -19.56%1-Year Change
- Medical DevicesIndustry
NEUROONE MD TCH (NMTC)
$3.34-$0.006 (-0.18%)
Annual
Quarterly
09/30/2025 | 09/30/2024 | 09/30/2023 | 09/30/2022 | ||
|---|---|---|---|---|---|
Income Statement | |||||
Total Operating Revenue | 9.1M +163.47% | 3.5M +76.86% | 2.0M +1,040.65% | 171,169 -3.92% | |
Cost of Revenue | 4.0M +66.70% | 2.4M +58.65% | 1.5M +518.24% | 241,963 -12.30% | |
Gross Profit | 5.1M +376.20% | 1.1M +136.50% | 456,517 +744.85% | -70,794 -27.58% | |
Sales and Marketing Expense | 7.4M -6.55% | 7.9M +14.08% | 6.9M -0.76% | 7.0M +1,959.82% | |
Research and Development Expense | -5.0M -1.62% | -5.1M -27.02% | -6.9M +40.80% | -4.9M +25.59% | |
Depreciation and Amortization Expense | 261,679 +6.03% | 246,791 +23.85% | 199,266 +67.99% | 118,620 +46.90% | |
Total Operating Expenses | 12.4M -4.62% | 13.0M -6.49% | 13.9M +16.44% | 11.9M +16.92% | |
Operating Profit | -4.2M -64.45% | -11.9M -0.57% | -12.0M +19.19% | -10.0M -1.83% | |
Interest Income | 170,492 N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Expense | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Interest Income and Expense and Net | 170,492 N/A | 0 N/A | 0 N/A | 0 +100.00% | |
Total Nonoperating Income and Expense | 170,492 +36.20% | 125,179 +30.72% | 95,759 +207.39% | 31,152 +1,120.37% | |
Income before Taxes | -3.6M -70.73% | -12.3M +3.87% | -11.9M +18.23% | -10.0M -1.83% | |
Income Taxes | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Extraordinary Items | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Net Income | -3.6M -70.73% | -12.3M +3.87% | -11.9M +18.60% | -10.0M +0.52% | |
Net Income from Continuing Operations Applicable to Common | -3.6M -70.73% | -12.3M +3.87% | -11.9M +18.60% | -10.0M +0.52% | |
Basic EPS and Net Income | -0.09 -80.43% | -0.46 -29.23% | -0.65 +3.17% | -0.63 -32.26% | |
Diluted EPS and Net Income | -0.09 -80.43% | -0.46 -29.23% | -0.65 +3.17% | -0.63 -32.26% | |
Basic Weighted Average Shares | 40.2M +50.03% | 26.8M +47.69% | 18.1M +13.27% | 16.0M +49.56% | |
Diluted Weighted Average Shares | 40.2M +50.03% | 26.8M +47.69% | 18.1M +13.27% | 16.0M +49.56% | |
Balance Sheet | |||||
Cash and Cash Equivalents | 6.6M +350.01% | 1.5M -72.57% | 5.3M -34.78% | 8.2M +18.24% | |
Short-Term Investments | N/A N/A | N/A N/A | N/A N/A | 3.0M N/A | |
Cash and Cash Equivalents and Short-Term Investments | 6.6M +350.01% | 1.5M -72.57% | 5.3M -52.23% | 11.1M +61.44% | |
Total Current Assets | 10.2M +120.83% | 4.6M -36.67% | 7.3M -39.94% | 12.2M +66.97% | |
Accumulated Depreciation | 798,823 +42.78% | 559,460 -100.00% | 335.0B N/A | N/A N/A | |
Property and Plant and Equipment and Net | 259,222 -37.81% | 416,843 -20.72% | 525,753 +48.69% | 353,599 +58.33% | |
Total Long-Term Assets | 282,142 -49.57% | 559,476 +6.41% | 525,753 +48.69% | 353,599 +58.33% | |
Total Assets | 10.8M +100.85% | 5.4M -33.68% | 8.1M -36.85% | 12.8M +61.52% | |
Income Taxes Payable | N/A N/A | N/A N/A | N/A N/A | 715,839 +11.11% | |
Total Short-Term Debt | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Total Current Liabilities | 2.3M +4.06% | 2.2M +23.46% | 1.8M -42.15% | 3.1M +162.22% | |
Total Long-Term Debt | N/A N/A | N/A N/A | 55,284 -53.76% | 119,556 -41.07% | |
Total Long-Term Liabilities | 1.4M -39.61% | 2.3M +4,123.12% | 55,284 -53.76% | 119,556 -41.07% | |
Total Liabilities | 3.7M -18.36% | 4.5M +146.11% | 1.8M -42.58% | 3.2M +132.43% | |
Retained Earnings | -78.6M +4.81% | -75.0M +19.65% | -62.7M +23.33% | -50.8M +24.49% | |
Total Stockholders Equity | 7.1M +760.39% | 822,013 -86.85% | 6.2M -34.93% | 9.6M +46.54% | |
Total Shares Outstanding | 50.0M +62.27% | 30.8M +28.78% | 23.9M +47.56% | 16.2M +35.03% | |
Cash Flow | |||||
Cash from Operating Activities | -2.8M -74.23% | -11.0M -14.55% | -12.9M +71.38% | -7.5M -12.59% | |
Capital Expenditures | 81,742 -31.99% | 120,197 -68.71% | 384,117 +39.56% | 275,226 +310.30% | |
Cash from Investing Activities | -81,742 -31.99% | -120,197 -104.54% | 2.6M +181.67% | -3.2M +4,737.23% | |
Dividends Paid | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Cash from Financing Activities | 8.0M +10.45% | 7.3M -1.75% | 7.4M -38.46% | 12.0M +4.23% | |
Financials Ratio | |||||
Gross Margin | 56.51% +80.74% | 31.27% +33.73% | 23.38% +156.53% | -41.36% -24.62% | |
Operating Margin | -46.46% -86.51% | -344.26% -43.78% | -612.32% -89.55% | -5,860.15% +2.17% | |
Return on Assets | -44.63% -75.60% | -182.93% +61.35% | -113.38% +17.70% | -96.33% -38.52% | |
Return on Equity | -91.34% -73.78% | -348.39% +132.86% | -149.61% +20.88% | -123.77% -46.38% | |
Revenue Growth | 163.47% +112.70% | 76.86% -92.61% | 1,040.65% +26,670.95% | -3.92% -103.83% | |
Current Ratio | 4.44 +112.21% | 2.09 -48.71% | 4.08 +3.82% | 3.93 -36.32% | |
Cash Ratio | 2.85 +332.45% | 0.66 -77.78% | 2.97 +12.74% | 2.63 -54.91% | |
Debt-to-Equity Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Debt-to-Assets Ratio | N/A N/A | N/A N/A | N/A N/A | N/A N/A | |
Earnings & Revenue History
Debt-to-Assets
Cash Flow